Petros Pharmaceuticals, Inc. PTPI
0.00 USD 0.00 (+0.00%)
At closeNov 5, 2026, 4:00 PM EST
0.04 +0.04 +1,233.33%
After hours · Nov 5, 4:00 PM ET
0.0028 Day range 0.0028
0.002 52-week range 0.022
- YTD
- -62.50%
- 1 year
- -85.00%
Financial health
Altman Z-Score
-47.45 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 4
- P/B 5
Valuation
P/E -0.0×
FY 2018 5y median -5.6× FY 2025
P/S 0.0×
FY 2018 5y median 15.5× FY 2025
P/B 0.8×
FY 2018 5y median 3.6× FY 2025
P/FCF -0.3×
FY 2018 5y median -9.4× FY 2025
EV/EBITDA 0.6×
FY 2018 5y median -8.8× FY 2025
EV/Sales 0.0×
FY 2018 5y median 16.2× FY 2025
FCF Yield -300.0%
FY 2018 5y median -10.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 72.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median -233.9% FY 2025
Net Margin 0.0%
FY 2018 5y median -140.2% FY 2025
ROE 66.7%
FY 2018 5y median -25.3% FY 2025
ROIC -161.7%
FY 2018 5y median -56.0% FY 2025
ROA 37.1%
FY 2018 5y median -24.2% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2018 FY 2025
Operating Income 73.7%
FY 2018 FY 2025
EPS (diluted) 53.3%
FY 2018 FY 2025
Free Cash Flow -156.3%
FY 2018 FY 2025
Financial Health
Current Ratio 2.3×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 2.3×
FY 2018 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2018 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2018 5y median -31.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31